Agenda

7:00 am

—

8:00 am

Expanding Beyond Binary: Reframing HER2 Expression in mBC

Breakfast and Non-CME/CE Bonus Presentation

Expanding Beyond Binary: Reframing HER2 Expression in mBC

Speaker: Kathleen K. Harnden, MD

8:00 am

—

8:15 am

Exhibit Hall Opens

8:15 am

—

8:20 am

Conference Welcome

Seth A. Wander, MD, PhD

8:20 am

—

9:45 am

Stephanie L. Graff, MD, FACP, FASCO; Claudine Isaacs, MD, FRCPC; Arielle J. Medford, MD; Seth A. Wander, MD, PhD

HR+

Session I

HR+

9:45 am

—

10:45 am

Refreshment Break and Non-CME/CE Bonus Presentation

Orserdu (elacestrant) – For patients with ER+/HER2-, ESR1-mutated mBC, upon progression on 1L ET + CDK4/6i

Refreshment Break and Non-CME/CE Bonus Presentation

Orserdu (elacestrant) – For patients with ER+/HER2-, ESR1-mutated mBC, upon progression on 1L ET + CDK4/6i

Speaker: Jules Cohen, MD

10:45 am

—

11:10 am

11:10 am

—

12:30 pm

Michael Danso, MD; Karthik V. Giridhar, MD; Kelly E. McCann, MD; Seth A. Wander, MD, PhD

HR+, Continued

Session I

HR+, Continued

‍

12:30 pm

—

1:30 pm

Clinical Case Reviews: Treatment of a Broad Range of Patients With HR+/HER2- Metastatic Breast Cancer

Lunch and Non-CME/CE Bonus Presentation

Clinical Case Reviews: Treatment of a Broad Range of Patients With HR+/HER2- Metastatic Breast Cancer

Speaker: Sramila Aithal, MD

1:30 pm

—

1:45 pm

1:45 pm

—

3:10 pm

Ana C. Garrido-Castro, MD; Reshma L. Mahtani, DO; Heather L. McArthur, MD, MPH, FASCO; Ana C. Sandoval Leon, MD

HER 2+

Session II

HER 2+

3:10 pm

—

3:25 pm

3:25 pm

—

4:45 pm

Mohamed Kahila, MD, MBBCh; Reshma L. Mahtani, DO; Sarah L. Sammons, MD; Paolo Tarantino, MD, PhD

HER 2+, Continued

Session II

HER 2+, Continued

4:45 pm

—

5:45 pm

Reception and Non-CME/CE Bonus Presentation

Addressing the Needs of Patients Across the HR+/HER2- Landscape: The Role of KISQALI in eBC and mBC

Reception and Non-CME/CE Bonus Presentation

Addressing the Needs of Patients Across the HR+/HER2- Landscape: The Role of KISQALI in eBC and mBC

Speaker: Elaine Macasiray

5:45 pm

—

Day One Adjourns

DAY 2

SATURDAY,

SEPTEMBER 13

7:15 am

—

7:30 am

—

8:30 am

Break: Exhibit Hall Opens

Speaker: Anamika Katoch, MD

8:30 am

—

8:45 am

8:45 am

—

10:10 am

Sarah Donahue, MPH, NP, AOCNP; Monica N. Fornier, MD; Erin M. Grannan, PharmD, BCOP; Jonathan W. Malara, PharmD, BCOP; Kristin E. Rojas, MD, FACS, FACOG

Supportive Care

Session III

Supportive Care

10:10 am

—

10:30 am

10:30 am

—

11:30 am

Supportive Care, Continued

Session III

Supportive Care, Continued

Blair S. Allais, MD, FAAD; Alan H. Baik, MD; Sarah Donahue, MPH, NP; Jonathan W. Malara, PharmD, BCOP

11:30 am

—

12:30 pm

Clinical applications of Cerianna (FES) PET/CT: A case-based perspective

Lunch and Non-CME/CE Bonus Presentation

Clinical applications of Cerianna (FES) PET/CT: A case-based perspective

Speakers: Joanne Mortimer, MD and Susan Cha, MD

12:30 pm

—

12:45 pm

12:45 pm

—

2:10 pm

Triple-Negative Breast Cancer

Session IV

Triple-Negative Breast Cancer

Filipa Lynce, MD; Rebecca A. Shatsky, MD; Hatem Soliman, MD; Joyce A. O'Shaughnessy, MD

2:10 pm

—

2:20 pm

Break

2:20 pm

—

4:00 pm

Triple-Negative Breast Cancer, Continued

Session IV

Triple-Negative Breast Cancer, Continued

G. Thomas Budd, MD; Antonio Giordano, MD, PhD ‍; Frederick Howard, MD; Linda T. Vahdat, MD, MBA

4:00 pm

—

Conference Adjourns

Please note all sessions are listed in Eastern Time. Agenda and credit amount subject to change.

Download Agenda

DAY 1

FRIDAY,

SEPTEMBER 12

6:45 am

—

7:00 am

—

8:00 am

Expanding Beyond Binary: Reframing HER2 Expression in mBC

Breakfast and Non-CME/CE Bonus Presentation

Expanding Beyond Binary: Reframing HER2 Expression in mBC

Speaker: Kathleen K. Harnden, MD

8:00 am

—

8:15 am

Exhibit Hall Opens

8:15 am

—

8:20 am

Conference Welcome

Seth A. Wander, MD, PhD

8:20 am

—

9:45 am

Stephanie L. Graff, MD, FACP, FASCO; Claudine Isaacs, MD, FRCPC; Arielle J. Medford, MD; Seth A. Wander, MD, PhD

HR+

Session I

HR+

9:45 am

—

10:45 am

Refreshment Break and Non-CME/CE Bonus Presentation

Orserdu (elacestrant) – For patients with ER+/HER2-, ESR1-mutated mBC, upon progression on 1L ET + CDK4/6i

Refreshment Break and Non-CME/CE Bonus Presentation

Orserdu (elacestrant) – For patients with ER+/HER2-, ESR1-mutated mBC, upon progression on 1L ET + CDK4/6i

Speaker: Jules Cohen, MD

10:45 am

—

11:10 am

11:10 am

—

12:30 pm

Michael Danso, MD; Karthik V. Giridhar, MD; Kelly E. McCann, MD; Seth A. Wander, MD, PhD

HR+, Continued

Session I

HR+, Continued

‍

12:30 pm

—

1:30 pm

Clinical Case Reviews: Treatment of a Broad Range of Patients With HR+/HER2- Metastatic Breast Cancer

Lunch and Non-CME/CE Bonus Presentation

Clinical Case Reviews: Treatment of a Broad Range of Patients With HR+/HER2- Metastatic Breast Cancer

Speaker: Sramila Aithal, MD

1:30 pm

—

1:45 pm

1:45 pm

—

3:10 pm

Ana C. Garrido-Castro, MD; Reshma L. Mahtani, DO; Heather L. McArthur, MD, MPH, FASCO; Ana C. Sandoval Leon, MD

HER 2+

Session II

HER 2+

3:10 pm

—

3:25 pm

3:25 pm

—

4:45 pm

Mohamed Kahila, MD, MBBCh; Reshma L. Mahtani, DO; Sarah L. Sammons, MD; Paolo Tarantino, MD, PhD

HER 2+, Continued

Session II

HER 2+, Continued

4:45 pm

—

5:45 pm

Reception and Non-CME/CE Bonus Presentation

Addressing the Needs of Patients Across the HR+/HER2- Landscape: The Role of KISQALI in eBC and mBC

Reception and Non-CME/CE Bonus Presentation

Addressing the Needs of Patients Across the HR+/HER2- Landscape: The Role of KISQALI in eBC and mBC

Speaker: Elaine Macasiray

5:45 pm

—

Day One Adjourns

Please note all sessions are listed in Eastern Time. Agenda and credit amount subject to change.

Download Agenda

DAY 2

SATURDAY,

SEPTEMBER 13

7:15 am

—

7:30 am

—

8:30 am

Break: Exhibit Hall Opens

Speaker: Anamika Katoch, MD

8:30 am

—

8:45 am

8:45 am

—

10:10 am

Sarah Donahue, MPH, NP, AOCNP; Monica N. Fornier, MD; Erin M. Grannan, PharmD, BCOP; Jonathan W. Malara, PharmD, BCOP; Kristin E. Rojas, MD, FACS, FACOG

Supportive Care

Session III

Supportive Care

10:10 am

—

10:30 am

10:30 am

—

11:30 am

Supportive Care, Continued

Session III

Supportive Care, Continued

Blair S. Allais, MD, FAAD; Alan H. Baik, MD; Sarah Donahue, MPH, NP; Jonathan W. Malara, PharmD, BCOP

11:30 am

—

12:30 pm

Clinical applications of Cerianna (FES) PET/CT: A case-based perspective

Lunch and Non-CME/CE Bonus Presentation

Clinical applications of Cerianna (FES) PET/CT: A case-based perspective

Speakers: Joanne Mortimer, MD and Susan Cha, MD

12:30 pm

—

12:45 pm

12:45 pm

—

2:10 pm

Triple-Negative Breast Cancer

Session IV

Triple-Negative Breast Cancer

Filipa Lynce, MD; Rebecca A. Shatsky, MD; Hatem Soliman, MD; Joyce A. O'Shaughnessy, MD

2:10 pm

—

2:20 pm

Break

2:20 pm

—

4:00 pm